AHA News: Heart Inflammation Risk Remains Rare After Third COVID-19 Vaccine Dose

TUESDAY, Nov. 1, 2022 (American Heart Association News) -- A third dose of the Moderna or Pfizer COVID-19 vaccine poses no more risk of heart inflammation than a second dose,

Related Keywords

California ,United States ,Boston ,Massachusetts ,Californians ,American ,Howard Sesso ,Mingsum Lee ,Centers For Disease ,Kaiser Permanente Los Angeles Medical Center ,American Heart Association News ,American Heart Association Scientific Sessions ,Kaiser Permanente Southern California Department Of Research ,American Heart Association ,Southern Californians ,Kaiser Permanente Los Angeles Medical ,Disease Control ,Kaiser Permanente Southern California ,Kaiser Permanente Southern California Department ,Consumer News ,Nose ,Vaccine ,Myocarditis ,Medicine ,Ardiology ,Harmacology ,Mmunology ,Hospital ,Natomy ,Inflammation ,Risk ,